Renovia’s leva® Pelvic Health System is First Femtech Offering Included in Product Library of Digital Therapeutics Alliance September 20, 2021
Verastem Oncology Announces Updated Investigator-Sponsored Phase 1/2 FRAME Study Data of VS-6766 with Defactinib in Low-Grade Serous Ovarian Cancer Showing Encouraging Response Rates and Progression-Free Survival Presented at ESMO 2021 September 20, 2021
Pulmocide’s Lead Drug Candidate Opelconazole (PC945) Granted Orphan Drug, Fast Track and Qualified Infectious Disease Product Designations by US FDA September 16, 2021
Immunitas Therapeutics Appoints Seng-Lai ‘Thomas’ Tan, Ph.D. as Chief Scientific Officer September 9, 2021
